Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Leukemia, Myeloid, Acute 18Leukemia 17Lymphoma 13Myelodysplastic Syndromes 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 7Hodgkin Disease 7Blast Crisis 7Myeloproliferative Disorders 6Multiple Myeloma 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Congenital Abnormalities 6Polycythemia Vera 5Neoplasms, Plasma Cell 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Lymphocytic, Chronic, B-Cell 5Graft vs Host Disease 5Thrombocythemia, Essential 4Primary Myelofibrosis 4Pdgfra-Associated Chronic Eosinophilic Leukemia 4Myelodysplastic-Myeloproliferative Diseases 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Neutrophilic, Chronic 4Hematologic Neoplasms 4Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3

Interventions

thymoglobulin 1plerixafor 1fosphenytoin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Photopheresis 1Phenytoin 1Melphalan 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Immunologic Deficiency Syndromes × Busulfan × Clear all
NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡